bioAffinity Technologies Q1 2025 10-Q Filing
Ticker: BIAFW · Form: 10-Q · Filed: May 15, 2025 · CIK: 1712762
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials, bio-research
Related Tickers: BIAF
TL;DR
BIAF filed Q1 2025 10-Q. Financials updated.
AI Summary
bioAffinity Technologies, Inc. filed its quarterly report for the period ending March 31, 2025. The company, focused on commercial physical and biological research, is incorporated in Delaware and headquartered in San Antonio, Texas. The filing details financial data for the first quarter of 2025, comparing it to the same period in 2024 and the fiscal year-end of 2024 and 2023.
Why It Matters
This filing provides investors with an update on bioAffinity Technologies' financial performance and position as of the first quarter of 2025, crucial for understanding the company's ongoing operations and future prospects.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it represents a standard quarterly update for a publicly traded company, but the specific financial health and operational risks are not detailed in this header information.
Key Numbers
- Q1 2025 — Reporting Period (The first quarter of 2025 financial data is reported.)
- 2025-03-31 — End of Reporting Period (The specific date for which financial information is reported.)
- 2024-12-31 — Previous Fiscal Year End (Used for comparison with current period financial data.)
Key Players & Entities
- bioAffinity Technologies, Inc. (company) — Filer of the 10-Q report
- 0001712762 (company) — Central Index Key for bioAffinity Technologies, Inc.
- 20250331 (date) — Conformed period of report
- 20250515 (date) — Filed as of date
- SAN ANTONIO (location) — City of business and mail address
- DE (location) — State of incorporation
- BIAF (company) — Ticker symbol for bioAffinity Technologies, Inc.
FAQ
What is the primary business of bioAffinity Technologies, Inc.?
bioAffinity Technologies, Inc. is engaged in Services - Commercial Physical & Biological Research, with SIC code 8731.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
When was this 10-Q filing submitted?
This filing was submitted on May 15, 2025.
Where is bioAffinity Technologies, Inc. headquartered?
The company is headquartered in San Antonio, Texas.
What are the key dates for which financial data is referenced in this filing header?
Key dates include the reporting period end of March 31, 2025, the filed as of date of May 15, 2025, and comparative periods such as December 31, 2024, and March 31, 2024.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding bioAffinity Technologies, Inc. (BIAFW).